vs
HAEMONETICS CORP（HAE）与Cloudflare, Inc.（NET）财务数据对比。点击上方公司名可切换其他公司
Cloudflare, Inc.的季度营收约是HAEMONETICS CORP的1.8倍（$614.5M vs $339.0M），HAEMONETICS CORP净利率更高（13.2% vs -2.0%，领先15.2%），Cloudflare, Inc.同比增速更快（33.6% vs -2.7%），Cloudflare, Inc.自由现金流更多（$105.2M vs $87.2M），过去两年Cloudflare, Inc.的营收复合增速更高（27.4% vs 0.4%）
豪洛捷（Haemonetics）是全球血液与血浆供应及服务提供商，于20世纪70年代由艾伦·（杰克）·莱瑟姆博士在马萨诸塞州内蒂克创立，业务围绕血液相关产品及配套服务展开，为全球医疗领域提供血液管理相关的专业解决方案。
Cloudflare是总部位于美国加利福尼亚州旧金山的科技企业，提供内容分发网络（CDN）、云网络安全、DDoS防护等多元互联网服务，同时是ICANN认证的域名注册商。其服务作为网站访客与客户托管服务商之间的反向代理，可有效提升访问性能，抵御恶意流量。
HAE vs NET — 直观对比
营收规模更大
NET
是对方的1.8倍
$339.0M
营收增速更快
NET
高出36.4%
-2.7%
净利率更高
HAE
高出15.2%
-2.0%
自由现金流更多
NET
多$18.0M
$87.2M
两年增速更快
NET
近两年复合增速
0.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $339.0M | $614.5M |
| 净利润 | $44.7M | $-12.1M |
| 毛利率 | 59.7% | 73.6% |
| 营业利润率 | 19.9% | -8.0% |
| 净利率 | 13.2% | -2.0% |
| 营收同比 | -2.7% | 33.6% |
| 净利润同比 | 19.3% | 6.0% |
| 每股收益（稀释后） | $0.95 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HAENET
| Q4 25 | $339.0M | $614.5M | ||
| Q3 25 | $327.3M | $562.0M | ||
| Q2 25 | $321.4M | $512.3M | ||
| Q1 25 | $330.6M | $479.1M | ||
| Q4 24 | $348.5M | $459.9M | ||
| Q3 24 | $345.5M | $430.1M | ||
| Q2 24 | $336.2M | $401.0M | ||
| Q1 24 | — | $378.6M |
净利润HAENET
| Q4 25 | $44.7M | $-12.1M | ||
| Q3 25 | $38.7M | $-1.3M | ||
| Q2 25 | $34.0M | $-50.4M | ||
| Q1 25 | $58.0M | $-38.5M | ||
| Q4 24 | $37.5M | $-12.8M | ||
| Q3 24 | $33.8M | $-15.3M | ||
| Q2 24 | $38.4M | $-15.1M | ||
| Q1 24 | — | $-35.5M |
毛利率HAENET
| Q4 25 | 59.7% | 73.6% | ||
| Q3 25 | 59.5% | 74.0% | ||
| Q2 25 | 59.8% | 74.9% | ||
| Q1 25 | 58.4% | 75.9% | ||
| Q4 24 | 55.5% | 76.4% | ||
| Q3 24 | 54.2% | 77.7% | ||
| Q2 24 | 52.0% | 77.8% | ||
| Q1 24 | — | 77.5% |
营业利润率HAENET
| Q4 25 | 19.9% | -8.0% | ||
| Q3 25 | 17.9% | -6.7% | ||
| Q2 25 | 16.8% | -13.1% | ||
| Q1 25 | 21.6% | -11.1% | ||
| Q4 24 | 16.9% | -7.5% | ||
| Q3 24 | 15.0% | -7.2% | ||
| Q2 24 | 11.8% | -8.7% | ||
| Q1 24 | — | -14.4% |
净利率HAENET
| Q4 25 | 13.2% | -2.0% | ||
| Q3 25 | 11.8% | -0.2% | ||
| Q2 25 | 10.6% | -9.8% | ||
| Q1 25 | 17.5% | -8.0% | ||
| Q4 24 | 10.8% | -2.8% | ||
| Q3 24 | 9.8% | -3.6% | ||
| Q2 24 | 11.4% | -3.8% | ||
| Q1 24 | — | -9.4% |
每股收益（稀释后）HAENET
| Q4 25 | $0.95 | $-0.03 | ||
| Q3 25 | $0.81 | $0.00 | ||
| Q2 25 | $0.70 | $-0.15 | ||
| Q1 25 | $1.17 | $-0.11 | ||
| Q4 24 | $0.74 | $-0.05 | ||
| Q3 24 | $0.66 | $-0.04 | ||
| Q2 24 | $0.74 | $-0.04 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $363.4M | $943.5M |
| 总债务越低越好 | $1.2B | — |
| 股东权益账面价值 | $911.5M | $1.5B |
| 总资产 | $2.5B | $6.0B |
| 负债/权益比越低杠杆越低 | 1.34× | — |
8季度趋势，按日历期对齐
现金及短期投资HAENET
| Q4 25 | $363.4M | $943.5M | ||
| Q3 25 | $296.4M | $1.1B | ||
| Q2 25 | $292.9M | $1.5B | ||
| Q1 25 | $306.8M | $204.5M | ||
| Q4 24 | $320.8M | $147.7M | ||
| Q3 24 | $299.3M | $182.9M | ||
| Q2 24 | $344.4M | $157.0M | ||
| Q1 24 | — | $254.4M |
总债务HAENET
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益HAENET
| Q4 25 | $911.5M | $1.5B | ||
| Q3 25 | $849.2M | $1.3B | ||
| Q2 25 | $882.3M | $1.2B | ||
| Q1 25 | $820.8M | $1.4B | ||
| Q4 24 | $906.9M | $1.0B | ||
| Q3 24 | $878.9M | $973.1M | ||
| Q2 24 | $905.4M | $881.5M | ||
| Q1 24 | — | $797.2M |
总资产HAENET
| Q4 25 | $2.5B | $6.0B | ||
| Q3 25 | $2.4B | $5.8B | ||
| Q2 25 | $2.5B | $5.6B | ||
| Q1 25 | $2.5B | $3.7B | ||
| Q4 24 | $2.5B | $3.3B | ||
| Q3 24 | $2.5B | $3.1B | ||
| Q2 24 | $2.5B | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比HAENET
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $93.6M | $190.4M |
| 自由现金流经营现金流 - 资本支出 | $87.2M | $105.2M |
| 自由现金流率自由现金流/营收 | 25.7% | 17.1% |
| 资本支出强度资本支出/营收 | 1.9% | 13.9% |
| 现金转化率经营现金流/净利润 | 2.09× | — |
| 过去12个月自由现金流最近4个季度 | $308.1M | $287.5M |
8季度趋势，按日历期对齐
经营现金流HAENET
| Q4 25 | $93.6M | $190.4M | ||
| Q3 25 | $111.3M | $167.1M | ||
| Q2 25 | $17.4M | $99.8M | ||
| Q1 25 | $116.6M | $145.8M | ||
| Q4 24 | $43.8M | $127.3M | ||
| Q3 24 | $48.8M | $104.7M | ||
| Q2 24 | $-27.4M | $74.8M | ||
| Q1 24 | — | $73.6M |
自由现金流HAENET
| Q4 25 | $87.2M | $105.2M | ||
| Q3 25 | $106.3M | $82.5M | ||
| Q2 25 | $13.6M | $39.9M | ||
| Q1 25 | $100.9M | $59.9M | ||
| Q4 24 | $35.2M | $54.2M | ||
| Q3 24 | $39.4M | $54.5M | ||
| Q2 24 | $-33.1M | $45.2M | ||
| Q1 24 | — | $41.5M |
自由现金流率HAENET
| Q4 25 | 25.7% | 17.1% | ||
| Q3 25 | 32.5% | 14.7% | ||
| Q2 25 | 4.2% | 7.8% | ||
| Q1 25 | 30.5% | 12.5% | ||
| Q4 24 | 10.1% | 11.8% | ||
| Q3 24 | 11.4% | 12.7% | ||
| Q2 24 | -9.8% | 11.3% | ||
| Q1 24 | — | 11.0% |
资本支出强度HAENET
| Q4 25 | 1.9% | 13.9% | ||
| Q3 25 | 1.5% | 15.1% | ||
| Q2 25 | 1.2% | 11.7% | ||
| Q1 25 | 4.7% | 17.9% | ||
| Q4 24 | 2.5% | 15.9% | ||
| Q3 24 | 2.7% | 11.7% | ||
| Q2 24 | 1.7% | 7.4% | ||
| Q1 24 | — | 8.5% |
现金转化率HAENET
| Q4 25 | 2.09× | — | ||
| Q3 25 | 2.88× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.01× | — | ||
| Q4 24 | 1.17× | — | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | -0.71× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
